Panel Aligns With FDA On Revised Regulation For Spinal Sphere Devices, Wheelchairs
This article was originally published in The Gray Sheet
Executive Summary
On Dec. 12, FDA’s Orthopaedic and Rehabilitation Devices panel recommended increasing its regulatory requirements for spinal sphere devices and mechanical wheelchairs and downclassifying stair-climbing wheelchairs.
You may also be interested in...
Regulatory News In Brief
Agency issues proposed orders to reclassify intra-aortic balloon and control systems, tuberculosis IVDs and stair-climbing wheelchairs. Industry mainly supports FDA’s communications draft guidance. More regulatory news.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.